According to Fortune Business Insights, The global arthroscopy fluid management disposables market size was USD 288.45 million in 2025. The market is projected to grow from USD 316.68 million in 2026 to USD 674.45 million by 2034, exhibiting a CAGR of 9.91% during the forecast period. North America dominated the arthroscopy fluid management disposables market with a market share of 54.69% in 2025.
Continue reading for more details:
https://www.fortunebusinessinsights.com/arthroscopy-fluid-management-disposables-market-104477
According to Fortune Business Insights, the Arthroscopy Fluid Management Disposables Market in 2026 is segmented by product type into pump management disposables and gravity management disposables, with the pump management disposables segment expected to hold the largest share within the arthroscopy fluid management disposables market owing to technological advancements that enhance fluid control and visualization during surgery. By application, the arthroscopy fluid management disposables market is categorized into hospitals, medical centers, and others, where hospitals are the leading end-user segment due to the high volume of orthopedic procedures performed in these settings. This segmentation highlights how different product types and applications contribute to the overall arthroscopy fluid management disposables market, addressing diverse procedural needs and supporting growing arthroscopy utilization worldwide.
Arthrex
Stryker
Smith & Nephew
DePuy
Zimmer Biomet
ConMed
Karl Storz
Richard Wolf
The arthroscopy fluid management disposables market is projected to grow significantly in 2026, with the global market size expected to rise from approximately USD 288.5 million in 2025 to a substantially higher value by 2032, exhibiting a robust compound annual growth rate through the forecast period. Growth in the arthroscopy fluid management disposables market is driven by increased adoption of minimally invasive arthroscopic procedures, rising prevalence of musculoskeletal injuries, and technological developments in fluid management systems that improve procedural efficiency and outcomes. The expanding number of orthopedic surgeries and favorable reimbursement landscapes in developed regions further propel the arthroscopy fluid management disposables market forward as clinicians seek improved disposables to support enhanced surgical performance.
Despite strong expansion prospects, the arthroscopy fluid management disposables market faces certain restraints that may temper growth. A decline in specific arthroscopic procedures, such as knee arthroscopies in some developed countries due to changing clinical recommendations, can negatively impact demand for fluid management disposables. Moreover, supply chain disruptions and elective surgery postponements observed during global health crises like COVID-19 affected the arthroscopy fluid management disposables market by reducing procedure volumes and delaying investment in new devices. Cost sensitivity in emerging markets and limited access to advanced arthroscopy facilities in some regions also act as challenges for broader adoption of arthroscopy fluid management disposables.
Regionally, North America dominates the arthroscopy fluid management disposables market, accounting for the largest share due to the strategic presence of major orthopedic device manufacturers, extensive healthcare infrastructure, and supportive reimbursement policies that encourage adoption of advanced disposables. Europe holds a significant position in the arthroscopy fluid management disposables market with strong healthcare systems and growing preference for minimally invasive procedures. The Asia Pacific arthroscopy fluid management disposables market is poised for rapid growth due to increasing healthcare expenditure, expanding medical device distribution networks, and rising awareness of advanced surgical techniques in countries like China and India. Latin America, the Middle East, and Africa represent emerging markets for arthroscopy fluid management disposables with gradual improvements in healthcare infrastructure and increasing procedural volumes.